Development of an epigenetic clock resistant to changes in immune cell composition.
Level 5 - mechanism / opinion, no new human data
Bench research and computational biomarker development using isolated human cell subsets and in vitro models
PubMed 39095531 · doi:10.1038/s42003-024-06609-4
What was done
The authors evaluated epigenetic age predictions across human CD8+ T cell subsets (naive vs. effector memory) and naive T cells from donors of varying chronological ages using existing DNA methylation clocks. To isolate cell-intrinsic aging from age-related shifts in leukocyte proportions, they developed 'IntrinClock'—a DNA methylation clock designed to be invariant across 10 immune cell types—and tested it in in vitro replicative senescence and OSKM-driven reprogramming models.
What was found
Naive CD8+ T cells had a predicted epigenetic age 15–20 years younger than effector memory CD8+ T cells from the same donor. Isolated naive T cells independently showed a progressive rise in epigenetic age with chronological donor age, confirming that standard clocks conflate cell composition with aging. IntrinClock remained stable across 10 immune cell types, showed increased epigenetic age during in vitro replicative senescence, and demonstrated age reversal during OSKM reprogramming. Specific error metrics, training statistics, and sample sizes were not reported in the abstract.
Why it matters
Standard bulk-tissue epigenetic clocks can mistakenly interpret shifts in immune cell subsets (such as the loss of naive T cells) as intrinsic biological aging. IntrinClock provides a method to measure cell-autonomous epigenetic aging without confounding by immune cell composition changes.
Limits
The abstract does not state the number of human donors or datasets used to build and validate the clock. Validation was confined to in vitro models of senescence and reprogramming, leaving clinical diagnostic and prognostic performance uncharacterized in the abstract.
Cited by
- context Epigenetic aging clocks measured in blood largely reflect the proportion of differentiated effector T cells accumulating in old age versus naive T cells.